Henkel and Agfa-Gevaert Signal Long-Term Growth with New FY26 Outlooks

The simultaneous release of full-year results and FY26 guidance from Henkel AG and Agfa-Gevaert marks a pivotal moment for European industrial and consumer markets. As both companies navigate a complex global economic landscape, their forward-looking statements suggest a transition from short-term crisis management to long-term structural optimization. Henkel, a powerhouse in adhesive technologies and consumer brands, and Agfa-Gevaert, a leader in imaging and healthcare IT, are providing the market with a roadmap for the next two years, emphasizing resilience and technological integration. This dual announcement underscores a growing trend among European blue-chip companies to offer longer-term visibility to investors who are increasingly wary of quarterly volatility.

Henkel’s performance continues to be anchored by its Adhesive Technologies business, which serves as a critical barometer for global manufacturing health. The company’s ability to maintain pricing power in this segment while managing fluctuating raw material costs has been a key driver of its recent fiscal success. Furthermore, the ongoing integration within its Consumer Brands division—formed from the merger of its Laundry & Home Care and Beauty Care units—is expected to yield significant cost synergies. The introduction of an FY26 outlook suggests that Henkel is confident in its ability to achieve its mid-term targets, likely focusing on organic sales growth and a further improvement in adjusted EBIT margins. The company is also doubling down on sustainable adhesive solutions, aiming to capture the growing demand for eco-friendly industrial processes in the automotive and electronics sectors.

“

The simultaneous release of full-year results and FY26 guidance from Henkel AG and Agfa-Gevaert marks a pivotal moment for European industrial and consumer markets.

Agfa-Gevaert, on the other hand, is in the midst of a profound digital pivot. The company’s FY results reflect the diverging paths of its business units: the steady decline of traditional radiology film contrasted with the high-growth potential of Healthcare IT and Digital Print & Chemicals. By introducing an FY26 outlook, Agfa-Gevaert is signaling to investors that its transformation is reaching a critical maturity phase. The focus for the next two years will likely center on scaling its cloud-native healthcare solutions and expanding its footprint in the industrial inkjet market, where it holds a competitive advantage in high-end applications. The integration of artificial intelligence into its imaging software is expected to be a primary driver of recurring revenue, moving the company away from its legacy hardware-heavy model.